Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04869085 · ClinicalTrials.gov registry record · NA

The Use of a Digital Application for Reporting Pain and Pain Management in Home Hospice

A NA study, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
88
Enrollment target

NCT04869085: Completed NA study, sponsored by Rush University Medical Center.

NCT04869085 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04869085, a NA study, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target

Study Summary

Poor adherence to pain management and high pain intensity associated with serious, advanced illness is a major public health concern. This randomized clinical trial will test the efficacy of a newly enhanced digital pain and pain management application (e-PainSupport) for use in a home hospice setting. The e-PainSupport application delivers an education module about pain management to patients and caregivers, expedites pain reporting to nurses, and facilitates adherence to pain management. The overall goal of the e-PainSupport application is to improve pain management and reduce patient pain intensity in the home hospice setting.

Primary Outcome

At least 20 percent change on the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity-Short Form 3a v1.0: 3 items: Worst pain and average pain in past 7 days scored from 1 = no pain, 2= mild, 3 = moderate, 4= severe, 5 = very severe pain. Higher scores indicates higher pain intensity.

Interventions

  • BEHAVIORAL e-PainSupport

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2021-04-21
Est. Completion 2024-01-31
Phase NA
Rush University Medical Center

320 total trials

What the finished NCT04869085 record still lists

NCT04869085 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which e-PainSupport is the first listed.

NCT04869085 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04869085 about?

NCT04869085 is a clinical study titled "The Use of a Digital Application for Reporting Pain and Pain Management in Home Hospice". Poor adherence to pain management and high pain intensity associated with serious, advanced illness is a major public health concern. This randomized clinical trial will test the efficacy of a newly enhanced digital pain and pain management application (e-PainSupport) for use in a home hospice setti...

What is the current status of trial NCT04869085?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2021-04-21. Estimated completion is 2024-01-31.

What interventions are being tested in trial NCT04869085?

The interventions under investigation include: e-PainSupport (BEHAVIORAL).

Who is sponsoring clinical trial NCT04869085?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04869085's enrollment target sits among peer trials

88 972nd of 2000 higher than 1,027 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04869085, the US trial registry maintained by the National Library of Medicine. NCT04869085 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.